{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:25:18Z","timestamp":1789809918616,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.clindermatol.2004.01.011","type":"journal-article","created":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T15:04:01Z","timestamp":1097161441000},"page":"289-295","source":"Crossref","is-referenced-by-count":67,"title":["Insulin resistance and obesity"],"prefix":"10.1016","volume":"22","author":[{"given":"Jerry R.","family":"Greenfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley V.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2004.01.011_BIB1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1440-1681.1997.tb02132.x","article-title":"Pathogenesis of the insulin resistance syndrome (syndrome X)","volume":"24","author":"Chisholm","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(17)42297-6","article-title":"The insulin signaling system","volume":"269","author":"White","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI6609","article-title":"Protein\u2013protein interaction in insulin signaling and the molecular mechanisms of insulin resistance","volume":"103","author":"Virkamaki","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(98)00300-3","article-title":"Insulin action and insulin resistance","volume":"105","author":"Hunter","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diabetes.45.5.633","article-title":"Abdominal fat and insulin resistance in normal and overweight women","volume":"45","author":"Carey","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/er.23.2.201","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diacare.23.4.441","article-title":"Increasing incidence of type 2 diabetes in the third millennium","volume":"23","author":"Samaras","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB8","first-page":"141","article-title":"The role of free fatty acids in muscle insulin resistance","volume":"12","author":"Kraegen","year":"1999","journal-title":"Diabetes Ann"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-201X.2003.01162.x","article-title":"The role of intramuscular lipid in insulin resistance","volume":"178","author":"Hegarty","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0898-6568(00)00110-8","article-title":"Signalling aspects of insulin resistance in skeletal muscle","volume":"12","author":"Schmitz-Peiffer","year":"2000","journal-title":"Cell Signal"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB12","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/en.2003-0580","article-title":"Minireview","volume":"144","author":"Rajala","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB13","doi-asserted-by":"crossref","first-page":"3G","DOI":"10.1016\/S0002-9149(02)02553-5","article-title":"Insulin resistance as the core defect in type 2 diabetes mellitus","volume":"90","author":"Goldstein","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB14","article-title":"Adiponectin and resistin","volume":"9","author":"Beltowski","year":"2003","journal-title":"Med Sci Monitor"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB15","doi-asserted-by":"crossref","unstructured":"Yang W-S, Lee W-J, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815\u20139","DOI":"10.1210\/jcem.86.8.7741"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB16","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2337\/diacare.26.9.2493","article-title":"Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect","volume":"26","author":"Satoh","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB17","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/en.2003-0373","article-title":"Minireview","volume":"144","author":"O'Rahilly","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/eje.0.1470435","article-title":"Insights into obesity and insulin resistance from the study of extreme human phenotypes","volume":"147","author":"O'Rahilly","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/11.12.1465","article-title":"Genotype-phenotype correlation in inherited severe insulin resistance","volume":"11","author":"Longo","year":"2002","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB21","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1210\/jc.2003-030034","article-title":"Identification and functional assessment of novel and known insulin receptor mutations in five patients with syndromes of severe insulin resistance","volume":"88","author":"Maassen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB22","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.86.7.3319","article-title":"Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors","volume":"86","author":"Ogilvy-Stuart","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB23","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or Seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype\u2013phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB25","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB26","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","article-title":"Kobberling type of familial partial lipodystrophy","volume":"26","author":"Herbst","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1463-1326.2001.00146.x","article-title":"Anti-retroviral therapy, insulin resistance and lipodystrophy","volume":"3","author":"Gan","year":"2001","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB28","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor\u2013associated lipodystrophy, hyperlipidaemia, and diabetes mellitus","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Clinical review 159. Human immunodeficiency virus\/highly active antiretroviral therapy-associated metabolic syndrome","volume":"88","author":"Leow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB30","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2337\/diabetes.51.11.3163","article-title":"Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor\u2013related lipodystrophy","volume":"51","author":"Gan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB31","first-page":"633","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"De Leo","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB34","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"51","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00125-002-0899-1","article-title":"Thiazolidinediones","volume":"45","author":"Furnsinn","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB37","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1210\/jc.2003-030435","article-title":"The metabolic syndrome","volume":"88","author":"Gurnell","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.med.52.1.239","article-title":"New oral therapies for type 2 diabetes mellitus","volume":"52","author":"Mudaliar","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clindermatol.2004.01.011_BIB39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrateinduced ovulation in women with polycystic ovary syndrome","volume":"79","author":"Ghazeeri","year":"2003","journal-title":"Fertil Steril"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:08:10Z","timestamp":1624694890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X04000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0738081X04000124"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2004.01.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}